<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37726611</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>21</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1875-8312</ISSN><JournalIssue CitedMedium="Internet"><Volume>38</Volume><Issue>9</Issue><PubDate><Year>2022</Year><Month>Sep</Month></PubDate></JournalIssue><Title>The international journal of cardiovascular imaging</Title><ISOAbbreviation>Int J Cardiovasc Imaging</ISOAbbreviation></Journal><ArticleTitle>CMR findings after COVID-19 and after COVID-19-vaccination-same but different?</ArticleTitle><Pagination><StartPage>2057</StartPage><EndPage>2071</EndPage><MedlinePgn>2057-2071</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10554-022-02623-x</ELocationID><Abstract><AbstractText>Cardiac involvement has been described in varying proportions of patients recovered from COVID-19 and proposed as a potential cause of prolonged symptoms, often described as post-COVID or long COVID syndrome. Recently, cardiac complications have been reported from COVID-19 vaccines as well. We aimed to compare CMR-findings in patients with clinical cardiac symptoms after COVID-19 and after vaccination. From May 2020 to May 2021, we included 104 patients with suspected cardiac involvement after COVID-19 who received a clinically indicated cardiac magnetic resonance (CMR) examination at a high-volume center. The mean time from first positive PCR to CMR was 112&#x2009; &#xb1; 76&#xa0;days. During their COVID-19 disease, 21% of patients required hospitalization, 17% supplemental oxygen and 7% mechanical ventilation. In 34 (32.7%) of patients, CMR provided a clinically relevant diagnosis: Isolated pericarditis in 10 (9.6%), %), acute myocarditis (both LLC) in 7 (6.7%), possible myocarditis (one LLC) in 5 (4.8%), ischemia in 4 (3.8%), recent infarction in 2 (1.9%), old infarction in 4 (3.8%), dilated cardiomyopathy in 3 (2.9%), hypertrophic cardiomyopathy in 2 (1.9%), aortic stenosis, pleural tumor and mitral valve prolapse each in 1 (1.0%). Between May 2021 and August 2021, we examined an additional 27 patients with suspected cardiac disease after COVID-19 vaccination. Of these, CMR provided at least one diagnosis in 22 (81.5%): Isolated pericarditis in 4 (14.8%), acute myocarditis in 9 (33.3%), possible myocarditis (acute or subsided) in 6 (22.2%), ischemia in 3 (37.5% out of 8 patients with stress test), isolated pericardial effusion (&gt;&#x2009;10&#xa0;mm) and non-compaction-cardiomyopathy each in 1 (3.7%). The number of myocarditis diagnoses after COVID-19 was highly dependent on the stringency of the myocarditis criteria applied. When including only cases of matching edema and LGE and excluding findings in the right ventricular insertion site, the number of cases dropped from 7 to 2 while the number of cases after COVID-19 vaccination remained unchanged at 9. While myocarditis is an overall rare side effect after COVID-19 vaccination, it is currently the leading cause of myocarditis in our institution due to the large number of vaccinations applied over the last months. Contrary to myocarditis after vaccination, LGE and edema in myocarditis after COVID-19 often did not match or were confined to the RV-insertion site. Whether these cases truly represent myocarditis or a different pathological entity is to be determined in further studies.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Doeblin</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-1511-8015</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine/Cardiology, Deutsches Herzzentrum Berlin, Berlin, Germany. doeblin@dhzb.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, Berlin, Germany. doeblin@dhzb.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jahnke</LastName><ForeName>Constantin</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine/Cardiology, Deutsches Herzzentrum Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schneider</LastName><ForeName>Matthias</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine/Cardiology, Deutsches Herzzentrum Berlin, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, Campus Virchow Klinikum, Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, Corporate Member of Freie Universit&#xe4;t Berlin and Humboldt-Universit&#xe4;t zu Berlin, Charit&#xe9;platz 1, 10117, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Tabatabaee</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine/Cardiology, Deutsches Herzzentrum Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goetze</LastName><ForeName>Collin</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine/Cardiology, Deutsches Herzzentrum Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weiss</LastName><ForeName>Karl J</ForeName><Initials>KJ</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine/Cardiology, Deutsches Herzzentrum Berlin, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tanacli</LastName><ForeName>Radu</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine/Cardiology, Deutsches Herzzentrum Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Faragli</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine/Cardiology, Deutsches Herzzentrum Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Witt</LastName><ForeName>Undine</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine/Cardiology, Deutsches Herzzentrum Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stehning</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Clinical Science, Philips Healthcare, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seidel</LastName><ForeName>Franziska</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Congenital Heart Disease, German Heart Center Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elsanhoury</LastName><ForeName>Ahmed</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>BIH Berlin Institute of Health at Charite (BIH), BIH Center for Regenerative Therapies (BCRT) Universit&#xe4;tsmedizin Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>K&#xfc;hne</LastName><ForeName>Titus</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Congenital Heart Disease, German Heart Center Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsch&#xf6;pe</LastName><ForeName>Carsten</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, Campus Virchow Klinikum, Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, Corporate Member of Freie Universit&#xe4;t Berlin and Humboldt-Universit&#xe4;t zu Berlin, Charit&#xe9;platz 1, 10117, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>BIH Berlin Institute of Health at Charite (BIH), BIH Center for Regenerative Therapies (BCRT) Universit&#xe4;tsmedizin Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pieske</LastName><ForeName>Burkert</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine/Cardiology, Deutsches Herzzentrum Berlin, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, Campus Virchow Klinikum, Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, Corporate Member of Freie Universit&#xe4;t Berlin and Humboldt-Universit&#xe4;t zu Berlin, Charit&#xe9;platz 1, 10117, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>BIH Berlin Institute of Health at Charite (BIH), BIH Center for Regenerative Therapies (BCRT) Universit&#xe4;tsmedizin Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kelle</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine/Cardiology, Deutsches Herzzentrum Berlin, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, Campus Virchow Klinikum, Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, Corporate Member of Freie Universit&#xe4;t Berlin and Humboldt-Universit&#xe4;t zu Berlin, Charit&#xe9;platz 1, 10117, Berlin, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>05</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Int J Cardiovasc Imaging</MedlineTA><NlmUniqueID>100969716</NlmUniqueID><ISSNLinking>1569-5794</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Int J Cardiovasc Imaging. 2022 Sep;38(9):2073-2075. doi: 10.1007/s10554-022-02651-7</RefSource><PMID Version="1">37726618</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009205" MajorTopicYN="Y">Myocarditis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009682" MajorTopicYN="N">Magnetic Resonance Spectroscopy</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CMR</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">COVID-19 vaccines</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Myocarditis</Keyword><Keyword MajorTopicYN="N">Pericarditis</Keyword></KeywordList><CoiStatement>PD owns stock of Siemens and Bayer. AF is a shareholder of BOCAhealthcare GmbH. CS is an employer of Philips Healthcare. BP reported receiving personal fees from Bayer, Bristol Myers Squib, Daiichi Sankyo, Medscape, MSD, Novartis, Stealth Peptides, and Vifor Pharma, and grants and personal fees from Astra-Zeneca. CT, BP and SK received funding from the DZHK (German Centre for Cardiovascular Research) and by the BMBF (German Ministry of Education and Research) and personal fees from Servier, outside of the current work. SK received an unrestricted research grant from Philips Healthcare and received lecture honoraria from Medis, NL.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>2</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>4</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>21</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>20</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>19</Day><Hour>23</Hour><Minute>40</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>5</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37726611</ArticleId><ArticleId IdType="pmc">PMC9097142</ArticleId><ArticleId IdType="doi">10.1007/s10554-022-02623-x</ArticleId><ArticleId IdType="pii">10.1007/s10554-022-02623-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Doeblin P, Kelle S (2021) Gong after COVID-19-myocarditis. Eur Heart J Cardiovasc Imaging (in press)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8194973</ArticleId><ArticleId IdType="pubmed">34080005</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng Q, Hu B, Zhang Y, Wang H, Zhou X, Hu W, et al. Suspected myocardial injury in patients with COVID-19: evidence from front-line clinical observation in Wuhan, China. Int J Cardiol. 2020;311:116&#x2013;121. doi: 10.1016/j.ijcard.2020.03.087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2020.03.087</ArticleId><ArticleId IdType="pmc">PMC7141178</ArticleId><ArticleId IdType="pubmed">32291207</ArticleId></ArticleIdList></Reference><Reference><Citation>Halushka MK, Vander Heide RS. Myocarditis is rare in COVID-19 autopsies: cardiovascular findings across 277 postmortem examinations. Cardiovasc Pathol. 2021;50:107300. doi: 10.1016/j.carpath.2020.107300.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.carpath.2020.107300</ArticleId><ArticleId IdType="pmc">PMC7583586</ArticleId><ArticleId IdType="pubmed">33132119</ArticleId></ArticleIdList></Reference><Reference><Citation>Tschope C, Sherif M, Anker MS, Geisel D, Kuehne T, Kelle S. COVID-19-convalescence phase unmasks a silent myocardial infarction due to coronary plaque rupture. ESC Heart Fail. 2021;8(2):971&#x2013;973. doi: 10.1002/ehf2.13186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ehf2.13186</ArticleId><ArticleId IdType="pmc">PMC8006695</ArticleId><ArticleId IdType="pubmed">33410259</ArticleId></ArticleIdList></Reference><Reference><Citation>Carfi A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg B, Mohn KG, Brokstad KA, Zhou F, Linchausen DW, Hansen BA, et al. Long COVID in a prospective cohort of home-isolated patients. Nat Med. 2021;27(9):1607&#x2013;1613. doi: 10.1038/s41591-021-01433-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01433-3</ArticleId><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah W, Hillman T, Playford ED, Hishmeh L. Managing the long term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline. BMJ. 2021;372:n136. doi: 10.1136/bmj.n136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n136</ArticleId><ArticleId IdType="pubmed">33483331</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedrich MG, Sechtem U, Schulz-Menger J, Holmvang G, Alakija P, Cooper LT, et al. Cardiovascular magnetic resonance in myocarditis: a JACC White Paper. J Am Coll Cardiol. 2009;53(17):1475&#x2013;1487. doi: 10.1016/j.jacc.2009.02.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2009.02.007</ArticleId><ArticleId IdType="pmc">PMC2743893</ArticleId><ArticleId IdType="pubmed">19389557</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira VM, Schulz-Menger J, Holmvang G, Kramer CM, Carbone I, Sechtem U, et al. Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations. J Am Coll Cardiol. 2018;72(24):3158&#x2013;3176. doi: 10.1016/j.jacc.2018.09.072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2018.09.072</ArticleId><ArticleId IdType="pubmed">30545455</ArticleId></ArticleIdList></Reference><Reference><Citation>Brito D, Meester S, Yanamala N, Patel HB, Balcik BJ, Casaclang-Verzosa G, et al. High prevalence of pericardial involvement in College Student Athletes recovering from COVID-19. JACC Cardiovasc Imaging. 2021;14(3):541&#x2013;555. doi: 10.1016/j.jcmg.2020.10.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2020.10.023</ArticleId><ArticleId IdType="pmc">PMC7641597</ArticleId><ArticleId IdType="pubmed">33223496</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen BH, Shi NN, Wu CW, An DA, Shi YX, Wesemann LD, et al. Early cardiac involvement in patients with acute COVID-19 infection identified by multiparametric cardiovascular magnetic resonance imaging. Eur Heart J Cardiovasc Imaging. 2021;22(8):844&#x2013;851. doi: 10.1093/ehjci/jeab042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjci/jeab042</ArticleId><ArticleId IdType="pmc">PMC7989521</ArticleId><ArticleId IdType="pubmed">33686389</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark DE, Parikh A, Dendy JM, Diamond AB, George-Durrett K, Fish FA, et al. COVID-19 myocardial pathology evaluation in athletes with cardiac magnetic resonance (COMPETE CMR) Circulation. 2021;143(6):609&#x2013;612. doi: 10.1161/CIRCULATIONAHA.120.052573.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.052573</ArticleId><ArticleId IdType="pmc">PMC7864610</ArticleId><ArticleId IdType="pubmed">33332151</ArticleId></ArticleIdList></Reference><Reference><Citation>Daniels CJ, Rajpal S, Greenshields JT, Rosenthal GL, Chung EH, Terrin M, et al. Prevalence of clinical and subclinical myocarditis in competitive athletes with recent SARS-CoV-2 infection: results from the big ten COVID-19 cardiac registry. JAMA Cardiol. 2021;6(9):1078&#x2013;1087. doi: 10.1001/jamacardio.2021.2065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2021.2065</ArticleId><ArticleId IdType="pmc">PMC8160916</ArticleId><ArticleId IdType="pubmed">34042947</ArticleId></ArticleIdList></Reference><Reference><Citation>Hendrickson BS, Stephens RE, Chang JV, Amburn JM, Pierotti LL, Johnson JL, et al. Cardiovascular evaluation after COVID-19 in 137 collegiate athletes: results of an algorithm-guided screening. Circulation. 2021;143(19):1926&#x2013;1928. doi: 10.1161/CIRCULATIONAHA.121.053982.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.121.053982</ArticleId><ArticleId IdType="pubmed">33970675</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Zhao P, Tang D, Zhu T, Han R, Zhan C, et al. Cardiac involvement in patients recovered from COVID-2019 identified using magnetic resonance imaging. JACC Cardiovasc Imaging. 2020;13(11):2330&#x2013;2339. doi: 10.1016/j.jcmg.2020.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2020.05.004</ArticleId><ArticleId IdType="pmc">PMC7214335</ArticleId><ArticleId IdType="pubmed">32763118</ArticleId></ArticleIdList></Reference><Reference><Citation>Knight DS, Kotecha T, Razvi Y, Chacko L, Brown JT, Jeetley PS, et al. COVID-19: myocardial injury in survivors. Circulation. 2020;142(11):1120&#x2013;1122. doi: 10.1161/CIRCULATIONAHA.120.049252.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.049252</ArticleId><ArticleId IdType="pmc">PMC7492396</ArticleId><ArticleId IdType="pubmed">32673505</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotecha T, Knight DS, Razvi Y, Kumar K, Vimalesvaran K, Thornton G, et al. Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance. Eur Heart J. 2021;42(19):1866&#x2013;1878. doi: 10.1093/eurheartj/ehab075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab075</ArticleId><ArticleId IdType="pmc">PMC7928984</ArticleId><ArticleId IdType="pubmed">33596594</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez MW, Tucker AM, Bloom OJ, Green G, DiFiori JP, Solomon G, et al. Prevalence of inflammatory heart disease among professional athletes with prior COVID-19 infection who received systematic return-to-play cardiac screening. JAMA Cardiol. 2021;6(7):745&#x2013;752. doi: 10.1001/jamacardio.2021.0565.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2021.0565</ArticleId><ArticleId IdType="pmc">PMC7934073</ArticleId><ArticleId IdType="pubmed">33662103</ArticleId></ArticleIdList></Reference><Reference><Citation>Moulson N, Petek BJ, Drezner JA, Harmon KG, Kliethermes SA, Patel MR, et al. SARS-CoV-2 cardiac involvement in young competitive athletes. Circulation. 2021;144(4):256&#x2013;266. doi: 10.1161/CIRCULATIONAHA.121.054824.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.121.054824</ArticleId><ArticleId IdType="pmc">PMC8300154</ArticleId><ArticleId IdType="pubmed">33866822</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann VO, Carerj ML, Wieters I, Fahim M, Arendt C, Hoffmann J, et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19) JAMA Cardiol. 2020;5(11):1265&#x2013;1273. doi: 10.1001/jamacardio.2020.3557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.3557</ArticleId><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajpal S, Tong MS, Borchers J, Zareba KM, Obarski TP, Simonetti OP, et al. Cardiovascular magnetic resonance findings in competitive athletes recovering from COVID-19 infection. JAMA Cardiol. 2021;6(1):116&#x2013;118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7489396</ArticleId><ArticleId IdType="pubmed">32915194</ArticleId></ArticleIdList></Reference><Reference><Citation>Starekova J, Bluemke DA, Bradham WS, Eckhardt LL, Grist TM, Kusmirek JE, et al. Evaluation for myocarditis in competitive student athletes recovering from coronavirus disease 2019 with cardiac magnetic resonance imaging. JAMA Cardiol. 2021;6(8):945&#x2013;950. doi: 10.1001/jamacardio.2020.7444.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.7444</ArticleId><ArticleId IdType="pmc">PMC7809616</ArticleId><ArticleId IdType="pubmed">33443537</ArticleId></ArticleIdList></Reference><Reference><Citation>Vago H, Szabo L, Dohy Z, Merkely B. Cardiac magnetic resonance findings in patients recovered from COVID-19: initial experiences in elite athletes. JACC Cardiovasc Imaging. 2020;14(6):1279&#x2013;1281. doi: 10.1016/j.jcmg.2020.11.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2020.11.014</ArticleId><ArticleId IdType="pmc">PMC7837171</ArticleId><ArticleId IdType="pubmed">33341416</ArticleId></ArticleIdList></Reference><Reference><Citation>Weckbach LT, Curta A, Bieber S, Kraechan A, Brado J, Hellmuth JC, et al. Myocardial inflammation and dysfunction in COVID-19-associated myocardial injury. Circ Cardiovasc Imaging. 2021;14(1):e012220. doi: 10.1161/CIRCIMAGING.120.011713.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCIMAGING.120.011713</ArticleId><ArticleId IdType="pubmed">33463366</ArticleId></ArticleIdList></Reference><Reference><Citation>Seidel F, Kuehne T, Kelle S, Doeblin P, Zieschang V, Tschoepe C, et al. Cardiovascular magnetic resonance findings in non-hospitalized paediatric patients after recovery from COVID-19. ESC Heart Fail. 2021;8(6):5583&#x2013;5588. doi: 10.1002/ehf2.13678.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ehf2.13678</ArticleId><ArticleId IdType="pmc">PMC8652950</ArticleId><ArticleId IdType="pubmed">34704672</ArticleId></ArticleIdList></Reference><Reference><Citation>Montgomery J, Ryan M, Engler R, Hoffman D, McClenathan B, Collins L, et al. Myocarditis following immunization with mRNA COVID-19 vaccines in members of the US military. JAMA Cardiol. 2021;6(10):1202&#x2013;1206. doi: 10.1001/jamacardio.2021.2833.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2021.2833</ArticleId><ArticleId IdType="pmc">PMC8243257</ArticleId><ArticleId IdType="pubmed">34185045</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HW, Jenista ER, Wendell DC, Azevedo CF, Campbell MJ, Darty SN, et al. Patients with acute myocarditis following mRNA COVID-19 vaccination. JAMA Cardiol. 2021;6(10):1196&#x2013;1201. doi: 10.1001/jamacardio.2021.2828.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2021.2828</ArticleId><ArticleId IdType="pmc">PMC8243258</ArticleId><ArticleId IdType="pubmed">34185046</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall M, Ferguson ID, Lewis P, Jaggi P, Gagliardo C, Collins JS, et al. Symptomatic acute myocarditis in 7 adolescents after pfizer-BioNTech COVID-19 vaccination. Pediatrics. 2021;148(3):e2021052478. doi: 10.1542/peds.2021-052478.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2021-052478</ArticleId><ArticleId IdType="pubmed">34088762</ArticleId></ArticleIdList></Reference><Reference><Citation>Hause AM, Gee J, Baggs J, Abara WE, Marquez P, Thompson D, et al. COVID-19 vaccine safety in adolescents aged 12&#x2013;17 years&#x2014;United States, December 14, 2020-July 16, 2021. MMWR Morb Mortal Wkly Rep. 2021;70(31):1053&#x2013;1058. doi: 10.15585/mmwr.mm7031e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7031e1</ArticleId><ArticleId IdType="pmc">PMC8367318</ArticleId><ArticleId IdType="pubmed">34351881</ArticleId></ArticleIdList></Reference><Reference><Citation>Witberg G, Barda N, Hoss S, Richter I, Wiessman M, Aviv Y, et al. Myocarditis after Covid-19 vaccination in a large Health Care Organization. N Engl J Med. 2021;385(23):2132&#x2013;2139. doi: 10.1056/NEJMoa2110737.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2110737</ArticleId><ArticleId IdType="pmc">PMC8531986</ArticleId><ArticleId IdType="pubmed">34614329</ArticleId></ArticleIdList></Reference><Reference><Citation>Oster ME, Shay DK, Su JR, Gee J, Creech CB, Broder KR, et al. Myocarditis cases reported after mRNA-Based COVID-19 vaccination in the US From December 2020 to August 2021. JAMA. 2022;327(4):331&#x2013;340. doi: 10.1001/jama.2021.24110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.24110</ArticleId><ArticleId IdType="pmc">PMC8790664</ArticleId><ArticleId IdType="pubmed">35076665</ArticleId></ArticleIdList></Reference><Reference><Citation>Fronza M, Thavendiranathan P, Chan V, Karur GR, Udell JA, Wald RM, et al (2022) Myocardial injury pattern at MRI in COVID-19 vaccine-associated myocarditis. Radiology 212559</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8856022</ArticleId><ArticleId IdType="pubmed">35166587</ArticleId></ArticleIdList></Reference><Reference><Citation>Jahnke C, Doeblin P, Tanacli R, Witt U, Schneider M, Stehning C, et al. Case series of potential cardiac inflammation associated with various SARS-CoV-2 vaccinations assessed by cardiac MRI. Front Cardiovasc Med. 2022;9:829392. doi: 10.3389/fcvm.2022.829392.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2022.829392</ArticleId><ArticleId IdType="pmc">PMC9024347</ArticleId><ArticleId IdType="pubmed">35463791</ArticleId></ArticleIdList></Reference><Reference><Citation>Schauer J, Buddhe S, Gulhane A, Sagiv E, Studer M, Colyer J, et al (2022) Persistent cardiac MRI findings in a cohort of adolescents with post COVID-19 mRNA vaccine myopericarditis. J Pediatr</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8957353</ArticleId><ArticleId IdType="pubmed">35351530</ArticleId></ArticleIdList></Reference><Reference><Citation>Amir G, Rotstein A, Razon Y, Beyersdorf GB, Barak-Corren Y, Godfrey ME, et al (2022) CMR imaging 6 months after myocarditis associated with the BNT162b2 mRNA COVID-19 vaccine. Pediatr Cardiol</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8941830</ArticleId><ArticleId IdType="pubmed">35320390</ArticleId></ArticleIdList></Reference><Reference><Citation>Barda N, Dagan N, Ben-Shlomo Y, Kepten E, Waxman J, Ohana R, et al. Safety of the BNT162b2 mRNA Covid-19 vaccine in a nationwide setting. N Engl J Med. 2021;385(12):1078&#x2013;1090. doi: 10.1056/NEJMoa2110475.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2110475</ArticleId><ArticleId IdType="pmc">PMC8427535</ArticleId><ArticleId IdType="pubmed">34432976</ArticleId></ArticleIdList></Reference><Reference><Citation>Gargano JW, Wallace M, Hadler SC, Langley G, Su JR, Oster ME, et al. Use of mRNA COVID-19 vaccine after reports of myocarditis among vaccine recipients: update from the Advisory Committee on Immunization Practices&#x2014;United States, June 2021. MMWR Morb Mortal Wkly Rep. 2021;70(27):977&#x2013;982. doi: 10.15585/mmwr.mm7027e2.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7027e2</ArticleId><ArticleId IdType="pmc">PMC8312754</ArticleId><ArticleId IdType="pubmed">34237049</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanacli R, Doeblin P, Gotze C, Zieschang V, Faragli A, Stehning C, et al. COVID-19 vs. classical myocarditis associated myocardial injury evaluated by cardiac magnetic resonance and endomyocardial biopsy. Front Cardiovasc Med. 2021;8:737257. doi: 10.3389/fcvm.2021.737257.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.737257</ArticleId><ArticleId IdType="pmc">PMC8739473</ArticleId><ArticleId IdType="pubmed">35004872</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelle S, Bucciarelli-Ducci C, Judd RM, Kwong RY, Simonetti O, Plein S, et al. Society for Cardiovascular Magnetic Resonance (SCMR) recommended CMR protocols for scanning patients with active or convalescent phase COVID-19 infection. J Cardiovasc Magn Reson. 2020;22(1):61. doi: 10.1186/s12968-020-00656-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12968-020-00656-6</ArticleId><ArticleId IdType="pmc">PMC7467754</ArticleId><ArticleId IdType="pubmed">32878639</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai AE, Schulz-Menger J, Berman D, Mahrholdt H, Han Y, Bandettini WP, et al. Gadobutrol-enhanced cardiac magnetic resonance imaging for detection of coronary artery disease. J Am Coll Cardiol. 2020;76(13):1536&#x2013;1547. doi: 10.1016/j.jacc.2020.07.060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.07.060</ArticleId><ArticleId IdType="pubmed">32972530</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulz-Menger J, Bluemke DA, Bremerich J, Flamm SD, Fogel MA, Friedrich MG, et al. Standardized image interpretation and post-processing in cardiovascular magnetic resonance&#x2014;2020 update. J Cardiovasc Magn Reson. 2020;22(1):19. doi: 10.1186/s12968-020-00610-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12968-020-00610-6</ArticleId><ArticleId IdType="pmc">PMC7066763</ArticleId><ArticleId IdType="pubmed">32160925</ArticleId></ArticleIdList></Reference><Reference><Citation>Robert Koch-Institut. COVID-19 Impfungen in Deutschland. https://raw.githubusercontent.com/robert-koch-institut/COVID-19-Impfungen_in_Deutschland/master/Aktuell_Deutschland_Bundeslaender_COVID-19-Impfungen.csv</Citation></Reference><Reference><Citation>LaGeSo Berlin. COVID-19 in Berlin, Fallzahlen und Indikatoren&#x2014;Gesamt&#xfc;bersicht. https://www.berlin.de/lageso/gesundheit/infektionskrankheiten/corona/tabelle-indikatoren-gesamtuebersicht/index.php/index/all.csv?q=</Citation></Reference><Reference><Citation>Cosyns B, Plein S, Nihoyanopoulos P, Smiseth O, Achenbach S, Andrade MJ, et al. European Association of Cardiovascular Imaging (EACVI) position paper: multimodality imaging in pericardial disease. Eur Heart J Cardiovasc Imaging. 2015;16(1):12&#x2013;31. doi: 10.1093/ehjci/jeu128.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjci/jeu128</ArticleId><ArticleId IdType="pubmed">25248336</ArticleId></ArticleIdList></Reference><Reference><Citation>Adler Y, Charron P, Imazio M, Badano L, Baron-Esquivias G, Bogaert J, et al. 2015 ESC guidelines for the diagnosis and management of pericardial diseases: the Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC) Endorsed by: the European Association for Cardio-Thoracic Surgery (EACTS) Eur Heart J. 2015;36(42):2921&#x2013;2964. doi: 10.1093/eurheartj/ehv318.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehv318</ArticleId><ArticleId IdType="pmc">PMC7539677</ArticleId><ArticleId IdType="pubmed">26320112</ArticleId></ArticleIdList></Reference><Reference><Citation>Boniface N, Kley J, Lisko J, Mikolich B, Mikolich JR (2014) Abstract 12863: non-cardiac chest pain: is it really? Circulation 130(Suppl 2)</Citation></Reference><Reference><Citation>Hudson B, Mantooth R, DeLaney M. Myocarditis and pericarditis after vaccination for COVID-19. J Am Coll Emerg Physicians Open. 2021;2(4):e12498. doi: 10.1002/emp2.12498.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/emp2.12498</ArticleId><ArticleId IdType="pmc">PMC8313036</ArticleId><ArticleId IdType="pubmed">34337595</ArticleId></ArticleIdList></Reference><Reference><Citation>Patone M, Mei XW, Handunnetthi L, Dixon S, Zaccardi F, Shankar-Hari M, et al. Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection. Nat Med. 2022;28(2):410&#x2013;422. doi: 10.1038/s41591-021-01630-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01630-0</ArticleId><ArticleId IdType="pmc">PMC8863574</ArticleId><ArticleId IdType="pubmed">34907393</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang RR, Kollengode R, Tan FL, Tai BC, Somani J, Fisher D, et al (2022) Myopericarditis following COVID-19 vaccination and non-COVID-19 vaccination: a systematic review and meta-analysis. Lancet Respir Med</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9000914</ArticleId><ArticleId IdType="pubmed">35421376</ArticleId></ArticleIdList></Reference><Reference><Citation>Corrales-Medina VF, Alvarez KN, Weissfeld LA, Angus DC, Chirinos JA, Chang CC, et al. Association between hospitalization for pneumonia and subsequent risk of cardiovascular disease. JAMA. 2015;313(3):264&#x2013;274. doi: 10.1001/jama.2014.18229.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2014.18229</ArticleId><ArticleId IdType="pmc">PMC4687729</ArticleId><ArticleId IdType="pubmed">25602997</ArticleId></ArticleIdList></Reference><Reference><Citation>Udell JA, Zawi R, Bhatt DL, Keshtkar-Jahromi M, Gaughran F, Phrommintikul A, et al. Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis. JAMA. 2013;310(16):1711&#x2013;1720. doi: 10.1001/jama.2013.279206.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2013.279206</ArticleId><ArticleId IdType="pubmed">24150467</ArticleId></ArticleIdList></Reference><Reference><Citation>Baral N, Adhikari P, Adhikari G, Karki S. Influenza myocarditis: a literature review. Cureus. 2020;12(12):e12007.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7793451</ArticleId><ArticleId IdType="pubmed">33437555</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagano N, Yano T, Fujita Y, Koyama M, Hasegawa R, Nakata J, et al. Hemodynamic collapse after influenza vaccination: a vaccine-induced fulminant myocarditis? Can J Cardiol. 2020;36(9):1554. doi: 10.1016/j.cjca.2020.05.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjca.2020.05.005</ArticleId><ArticleId IdType="pubmed">32413549</ArticleId></ArticleIdList></Reference><Reference><Citation>Tschope C, Ammirati E, Bozkurt B, Caforio ALP, Cooper LT, Felix SB, et al. Myocarditis and inflammatory cardiomyopathy: current evidence and future directions. Nat Rev Cardiol. 2021;18(3):169&#x2013;193. doi: 10.1038/s41569-020-00435-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-020-00435-x</ArticleId><ArticleId IdType="pmc">PMC7548534</ArticleId><ArticleId IdType="pubmed">33046850</ArticleId></ArticleIdList></Reference><Reference><Citation>Caforio AL, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013;34(33):2636&#x2013;2648. doi: 10.1093/eurheartj/eht210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/eht210</ArticleId><ArticleId IdType="pubmed">23824828</ArticleId></ArticleIdList></Reference><Reference><Citation>Francone M, Chimenti C, Galea N, Scopelliti F, Verardo R, Galea R, et al. CMR sensitivity varies with clinical presentation and extent of cell necrosis in biopsy-proven acute myocarditis. JACC Cardiovasc Imaging. 2014;7(3):254&#x2013;263. doi: 10.1016/j.jcmg.2013.10.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2013.10.011</ArticleId><ArticleId IdType="pubmed">24560214</ArticleId></ArticleIdList></Reference><Reference><Citation>Doeblin P, Hashemi D, Tanacli R, Lapinskas T, Gebker R, Stehning C, et al. CMR tissue characterization in patients with HFmrEF. J Clin Med. 2019;8(11):1877. doi: 10.3390/jcm8111877.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm8111877</ArticleId><ArticleId IdType="pmc">PMC6912482</ArticleId><ArticleId IdType="pubmed">31694263</ArticleId></ArticleIdList></Reference><Reference><Citation>Messroghli DR, Moon JC, Ferreira VM, Grosse-Wortmann L, He T, Kellman P, et al. Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: a consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI) J Cardiovasc Magn Reson. 2017;19(1):75. doi: 10.1186/s12968-017-0389-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12968-017-0389-8</ArticleId><ArticleId IdType="pmc">PMC5633041</ArticleId><ArticleId IdType="pubmed">28992817</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>